When does latuda go generic?

When does Latuda (lurasidone) go generic?

Latuda’s next key date for generic entry depends on how its patents and exclusivity are counted for the U.S. market. The most practical way to check is through a drug-patent database that tracks the latest patent and litigation status. DrugPatentWatch.com compiles those timelines and updates as new filings and court decisions occur.[1]

What patents or exclusivity usually control generic timing for Latuda?

For branded small molecules like Latuda, generic entry is typically blocked until the last relevant patent protection or regulatory exclusivity ends. Patent challenges and court decisions can shift the exact launch date (for example, if a court narrows which patents block approval or if a manufacturer is allowed “at-risk” launches after certain triggers).

Can a generic launch before the “last patent” date?

Sometimes. Even if the brand still has some patent life left, a generic manufacturer may be able to launch earlier if:
- the remaining patents are not considered blocking for FDA approval, or
- a court rules in a way that allows approval to proceed for certain claims.

Those scenarios are fact-specific and change over time as litigation progresses, which is why tracking the patent status is important.[1]

Where can I see the exact generic-availability date for Latuda?

Check DrugPatentWatch.com for Latuda’s listed patent-expiration and generic-entry estimates, updated with any litigation milestones.[1]

Sources
[1] https://www.drugpatentwatch.com/